New Retina Radio is a place to hear stories about retina that are told nowhere else.
…
continue reading
To the Point is a podcast aimed at helping optometrists build their dry eye practices.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
From Trials to the Clinic: Using a Therapy With a Novel MOA to Treat Patients With DME
29:41
29:41
Play later
Play later
Lists
Like
Liked
29:41
One of the challenges associated with current anti-VEGF therapies for the management of DME is the need for frequent injections and the potential impact on adherence and vision outcomes. Join Dr. John Kitchens and Dr. Maria Berrocal as they share their experiences treating their DME patients using a therapy with a novel mechanism of action, and how…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Knowledge on Dry Eye, Diet, and Lifestyle to Share With Patients
28:01
28:01
Play later
Play later
Lists
Like
Liked
28:01
Julie Poteet, OD, MS, CNS, FONS, joins Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, on this month’s episode of To the Point. An expert on nutrition and ocular health, Dr. Poteet discusses what the research has shown regarding the benefits of dietary supplementation for managing ocular surface disease, new products on the market,…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Retina Radio Journal Club w/ VBS: RVOs During the COVID Pandemic
15:15
15:15
Play later
Play later
Lists
Like
Liked
15:15
What did a review of the AAO IRIS Registry reveal about the rates of retinal vein occlusion (RVO) during the COVID-19 pandemic? Moderator Katherine Talcott, MD, sits down with Phoebe Mellen, MD, and Kyle Kovacs, MD, to review the study's conclusion that RVO rates did not increase during the pandemic, discuss challenges about talking to patients see…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
A Treatment With a Novel MOA for Patients With nAMD and DME: Perspectives From the Real World
34:24
34:24
Play later
Play later
Lists
Like
Liked
34:24
Recent studies have proven the therapeutic viability of a different approach in treating retinal vascular diseases. Join Dr. John Kitchens, Dr. Margaret Chang, and Dr. David Chin Yee as they discuss their clinical experiences using a therapy with a novel mechanism of action in patients with nAMD and DME. And, learn how they approach managing patien…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
AMD and DME Applications in the Retina Practice: Real-world Data
21:08
21:08
Play later
Play later
Lists
Like
Liked
21:08
In the second episode of this 2-part series, moderator Paul Hahn, MD, PhD, and panelists Durga Borkar, MD, MMCi, and Ted Leng, MD, turn to the findings of FARETINA-AMD and FARETINA-DME, which rely on real-world outcomes as documented in the AAO IRIS Registry. What can retina specialists learn from these studies, and how might these studies' finding…
…
continue reading
Jennifer Shaba, OD, joins Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, on the latest episode to share her story about opening her own dry eye practice focused on regenerative medicine and holistic eye care. Dr. Shaba offers advice for optometrists at the very beginning of their own journey in dry eye.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
ARVO 2024 Coverage: UWF Leakage in Protocol AA, Machine Learning, and GA's Link to Anxiety/Depression
22:55
22:55
Play later
Play later
Lists
Like
Liked
22:55
Protocol AA might be complete—but analysis of its data is far from over. What did that study’s data tell us about the relationship between leakage and DR severity? Justis Ehlers, MD, breaks down what he and his team uncovered when examining ultra-widefield images from Protocol AA, and helps us understand how machine learning might be used in future…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Retina Radio Journal Club with VBS: New Retina Radio Journal Club with VBS: Is Buckling Effective for RRD in Patients at Risk for PVR?
13:57
13:57
Play later
Play later
Lists
Like
Liked
13:57
How do outcomes differ for RRD patients at risk of PVR following PPV alone or combined PPV/scleral buckling? Moderator David Xu, MD, hears from panelists Barton Blackorby, MD, and Prethy Rao, MD, MPH, about a recent peer-reviewed paper published in Ophthalmology Retina covering surgical outcomes of patients with RRD who were considered high risk fo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
ARVO 2024 Coverage: ≥20-week Dosing in PULSAR and TENAYA/LUCERNE
16:00
16:00
Play later
Play later
Lists
Like
Liked
16:00
Could next-generation anti-VEGF agents such as faricimab (Vabysmo, Genentech/Roche) and high-dose aflibercept (Eylea HD, Regeneron) be dosed as infrequently as every 20 weeks without sacrificing efficacy? And even if there are data that suggest that finding, would anyone actually adopt an interval that long in wet AMD patients? Philip Storey, MD, f…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
GA Options in Clinical Therapy, Part 2: Real-world Cases in GA
17:20
17:20
Play later
Play later
Lists
Like
Liked
17:20
David RP Almeida, MD, PhD, MBA; Lisa Faia, MD; and Chris Riemann, MD, return for the second episode in this podcast miniseries, in which they review a trio of real-world GA cases, explore what early responses to treatment look like, and ask how to address GA in the presence of wet AMD.By Retina Today
…
continue reading
![Artwork](/static/images/128pixel.png)
1
GA Options in Clinical Therapy, Part 1: Patient Selection and Treatment Strategies
23:42
23:42
Play later
Play later
Lists
Like
Liked
23:42
Join David RP Almeida, MD, PhD, MBA; Lisa Faia, MD; and Chris Riemann, MD, as they assess which clinical and non-clinical characteristics drive their decision-making in patients with geographic atrophy (GA). After the break, Dr. Faia shares a real-world case from her clinic in which a patient who was lost to follow-up returns to consider treatment.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
AMD and DME Applications in the Retina Practice: RCT Comparison
21:13
21:13
Play later
Play later
Lists
Like
Liked
21:13
What conclusions can be drawn from a cross-trial comparison of randomized clinical trials assessing the safety and efficacy of anti-VEGF agents used in the treatment of AMD and DME? Paul Hahn, MD, PhD, sits down with Durga Borkar, MD, MMCi, and Ted Leng, MD, to review a recent presentation by Dr. Leng on this topic, and to examine the clinical rele…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
An Interview With the Inventor of Rinsada
36:25
36:25
Play later
Play later
Lists
Like
Liked
36:25
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, are joined by retina specialist Srinivas Kondapalli, MD, who developed the Rinsada Irrigating Lid Retractor, which effectively cleanses the conjunctival fornix, palpebral conjunctiva, and bulbar conjunctiva.By Modern Optometry
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The State of Biosimilars: Integration of Biosimilars into a Retina Practice
22:03
22:03
Play later
Play later
Lists
Like
Liked
22:03
Biosimilars in retina are here. How are practices integrating them into their clinics? And how do they navigate issues around payer policy, protocol changes, and ensuring continuity of care? Moderator John Kitchens, MD, sits down with retina specialist Dave Brown, MD, and Kristin Yockus, the VP of Process Integrations at Retina Consultants of Ameri…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT
15:48
15:48
Play later
Play later
Lists
Like
Liked
15:48
How do endophthalmitis rates after intravitreal injection differ after using povidone-iodine compared with chlorhexidine? Moderator Sruthi Arepalli, MD, hears from panelists Vaidehi Dedania, MD, and Rebecca Soares, MD, MPH, about a recent peer-reviewed retrospective cohort study on this topic. After the break, the trio discuss how to manage patient…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Successful Management of Vitreous Opacities
25:38
25:38
Play later
Play later
Lists
Like
Liked
25:38
Performing surgery for symptomatic vitreous opacities (SVO) was once verboten in retina medicine, but the field has seen a sea-change in mindset over the past decade. In this podcast, moderator John Kitchens, MD, is joined by Edwin H. Ryan, MD; Christina Y. Weng, MD, MBA; and Alison Bozung, OD, to explore why surgery for SVO has become more palatab…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Hear the Journey of the OD Behind the Crystal Tear Report
39:16
39:16
Play later
Play later
Lists
Like
Liked
39:16
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, catch up with Crystal M. Brimer, OD, FAAO, to talk about her prolific journey in dry eye. Dr. Brimer discusses opening her own practice, creating the Dry Eye Institute to promote education among eye care providers, and shares tips to help other ODs to get started or revitalize their d…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Retina Radio Journal Club with VBS: Visual Outcomes Following Surgical RRD Repair Relative to Foveal Status and Time of Surgery
20:17
20:17
Play later
Play later
Lists
Like
Liked
20:17
Do the status of the fovea and/or the timing of surgery affect visual outcomes following RRD repair? Join New Retina Radio Journal Club host Lediana Goduni, MD, as she and panelists Matt Starr, MD, and Joshua Uhr, MD, dissect the findings of a recent paper exploring this question. After the break, the trio discusses tactics for overcoming challenge…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Practice, Noh Problem: Lessons From Opening a Cold Start Practice
28:41
28:41
Play later
Play later
Lists
Like
Liked
28:41
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, welcome this month’s guest, Ada Noh, OD. Dr. Noh shares her story of how she came to open her very own practice, dedicated solely to dry eye, in a brand new city. She talks about building up her patient base, networking with local providers, and lessons she learned along the way.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Treating Geographic Atrophy (GA) In Your Practice
17:47
17:47
Play later
Play later
Lists
Like
Liked
17:47
Sponsored by Apellis Pharmaceuticals. Scott Walter, MD, and Esther Kim, MD, join John W. Kitchens, MD, to discuss how they treat GA in their practices. Listen to gain expert insights as Drs. Kim, Walter, and Kitchens each share their experiences with this treatment. They also share best practices for dosing based on trial data.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Diagnosing Geographic Atrophy (GA) and Identifying Eligible Patients For Therapy
20:39
20:39
Play later
Play later
Lists
Like
Liked
20:39
Sponsored by Apellis Pharmaceuticals. John W. Kitchens, MD, invites Scott Walter, MD, and Esther Kim, MD, to discuss best practices for identifying appropriate patients with GA for treatment. Gain perspectives on patient selection, patient education, and safety considerations.By Retina Today
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The State of Biosimilars: How We Got Here and What It Means for Practice
25:19
25:19
Play later
Play later
Lists
Like
Liked
25:19
Two biosimilars are approved for use in retina by the US FDA—and more will be approved in the coming years. What exactly are biosimilars? What benefit might they provide? And how confident are retina specialist that biosimilars will deliver safe, high-quality care? Moderator John Kitchens, MD, sits down with retina specialists Carl Awh, MD, and Fir…
…
continue reading
The field of retina has made significant strides when it comes to diversity, equity, and inclusion since Julia A. Haller, MD, penned her inspirational 2015 JAMA Ophthalmology editorial, Cherchez la Femme. The ever-growing body of research on this topic stands as a testament to her commitment to understanding the gaps in diversity, particularly in t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Is Radio Frequency a Worthwhile Investment for Your Dry Eye Toolkit?
27:47
27:47
Play later
Play later
Lists
Like
Liked
27:47
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, interview Keylee Brown, OD, to learn how she came to offer radio frequency therapy in her dry eye clinic. Dr. Brown talks about how the technology works with intense pulsed light, how she educates patients about it, fits it into her workflow, and the rewarding clinical results she has…
…
continue reading
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, kick off 2024 with a conversation about several new and anticipated products for treating ocular surface disease, including cyclosporine ophthalmic solution 0.1% (Vevye, Harrow), perfluorohexyloctane ophthalmic solution (Meibo, Bausch + Lomb), and lotilaner ophthalmic solution 0.25% (…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
AAO ’23: Downward Trends in Reimbursement and ChatGPT in the Retina Clinic
35:53
35:53
Play later
Play later
Lists
Like
Liked
35:53
Reimbursements for vitreoretinal surgery have plummeted in the past decade. How dire is the situation? John Thompson, MD, updates listeners on the trends in Medicare reimbursement for a variety of vitreoretinal surgeries, imaging tests, and E&M visits—all of which have implications for the future of care and access to providers. After the break, Ra…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Retina Radio Journal Club: Intentional Suspension of Therapy in Wet AMD
15:32
15:32
Play later
Play later
Lists
Like
Liked
15:32
What are the consequences to intentional suspension of anti-VEGF therapy in wet AMD patients? Join moderator Sruthi Arepalli, MD, and panelists Rebecca Soares, MD, MPH, and Vaidehi Dedania, MD, as they explore the circumstances under which treatment might be suspended, examine a paper that described the consequences of treatment suspension, and rev…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
AAO ’23: Real-World Faricimab Patterns and Improving GA Assessments
22:13
22:13
Play later
Play later
Lists
Like
Liked
22:13
The FARETINA-AMD study group assessed approximately 23,000 patients with wet AMD who had received at least one dose of faricimab (Vabysmo, Genentech/Roche). What have they found? Sophie Bakri, MD, summarizes the findings of an IRIS Registry review, which uncovered data about who has been dosed with faricimab, how frequently extended dosing interval…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Retina Radio AAO Late-Breakers: PULSAR at 96 Weeks and Home OCT in Wet AMD
25:59
25:59
Play later
Play later
Lists
Like
Liked
25:59
They’re here: the 96-week data on aflibercept 8 mg (Eylea, Regeneron) in wet AMD. Jean-Francois Korobelnik, MD, PhD stops by to review the 96-week data from PULSAR. How closely did the 96-week results match those at 48 weeks? And how many patients could be extended to 16-, 20-, or even 24-week intervals? Also, W. Lloyd Clark, MD, joins the show to …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Retina Radio Journal Club: Prophylactic Laser for Lattice Degeneration in Fellow Eyes After RRD Repair
16:44
16:44
Play later
Play later
Lists
Like
Liked
16:44
How effective is prophylactic laser for preventing fellow eye RT/RRD in patients with lattice degeneration who underwent uncomplicated primary RRD repair? NRR Journal Club with VBS moderator David Xu, MD, and panelists Prethy Rao, MD, and Barton Blackorby, MD, summarize a recent study that explored rates of fellow eye RT/RRD in this patient populat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Retina Radio AAO Late-Breakers: ALTITUDE and DIAMOND
21:16
21:16
Play later
Play later
Lists
Like
Liked
21:16
RGX-314 (Regenxbio) could be a one-time gene therapy that addresses diabetic retinopathy. How did it perform in the phase 2 ALTITUDE study? Mark Barakat, MD, shares 1-year safety and efficacy findings from the first two dosing levels of RGX-314 in patients with DR. What are the data? And what’s coming next? And Hani Salehi-Had, MD, joins the show t…
…
continue reading
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, welcome guest Jacqueline Theis, OD, FAAO, who shares her pearls for treating patients with dry eye and a neurologic condition or injury. She explains how to determine whether a patient’s dry eye symptoms are simply dry eye alone, or if they may be related to neurologic problem, and wh…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Retina Radio Journal Club: Are Postpartum Retinal Detachment Rates Linked to Method of Delivery?
16:58
16:58
Play later
Play later
Lists
Like
Liked
16:58
Do patients with a history of retinal detachment (RD) experience higher rates of postpartum RD based on whether they delivered vaginally or via caesarean section? Join NRR Journal Club with VBS moderator Lediana Goduni, MD, and panelists Matt Starr, MD, and Joshua Uhr, MD, as they recap a new paper on this topic. After the break, the group reviews …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Considerations for Use of Two Newly Approved Drugs
31:12
31:12
Play later
Play later
Lists
Like
Liked
31:12
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss factors to consider when bringing perfluorohexyloctane ophthalmic solution (Miebo, Bausch + Lomb) and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals) into your clinical practice.By Modern Optometry
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Chronic Postoperative Inflammation: Patient Scenarios
21:16
21:16
Play later
Play later
Lists
Like
Liked
21:16
How do retina specialists manage real-world patients with chronic postoperative inflammation? Host John Kitchens, MD, poses various scenarios to panelists Brian Do, MD, and Katherine Talcott, MD, to better understand their approaches to controlling postoperative inflammation in a variety of patients. After the break, the group focuses on the real-w…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Retina Radio Journal Club: Cost Evaluation in DME Therapy
15:25
15:25
Play later
Play later
Lists
Like
Liked
15:25
Researchers performed a cost analysis of the DRCR Retina Network’s Protocol AC study comparing on-label and off-label anti-VEGF use in DME therapy. What did they determine? Moderator Priya Vakharia, MD, invites panelists Sruthi Arepalli, MD, and Vaidehi Dedania, MD, to review the details of this economic examination. After the break, they explore h…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How Imaging Helps Clinics Integrate New Therapies in GA
16:26
16:26
Play later
Play later
Lists
Like
Liked
16:26
How do retina specialists introduce new therapies to patients, and how does thoughtful use of imaging help providers integrate new treatments into their clinics? Moderator Aleksandra Rachitskaya, MD, joins panelists Mrinali Gupta, MD, and Katherine Talcott, MD, to review how innovations in imaging software have helped onboard GA therapies in real-w…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Luminaries in Retina: Kirk Packo, MD, FACS (Part 2)
35:07
35:07
Play later
Play later
Lists
Like
Liked
35:07
In part 2 of this special podcast interview with John W. Kitchens, MD, and Kirk Packo, MD, FACS, they dive into Dr. Packo's involvement in the creation of AAO subspecialty day, his passion for honoring the history of retina, and his assistance in advocating for vitreoretinal surgery improvements. This podcast is editorially independent.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Luminaries in Retina: Kirk Packo, MD, FACS (Part 1)
40:27
40:27
Play later
Play later
Lists
Like
Liked
40:27
John W. Kitchens, MD, interviews Kirk Packo, MD, FACS, around his triumphant career and his decision to retire from practicing medicine following an unexpected diagnosis. In part 1 of 2, Dr. Packo describes his early career goals, his experience with residency matching, his background in acting and directing, and his passion for educating. This pod…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Chronic Postoperative Inflammation: Steroids’ Role in Treatment
23:14
23:14
Play later
Play later
Lists
Like
Liked
23:14
How do retina specialists manage patients who present with postoperative inflammation following cataract surgery? Host John Kitchens, MD, and panelists Vaidehi Dedania, MD, and David Eichenbaum, MD, explore the role steroids play in inflammation reduction and examine whether and why extended-release steroids are needed. After the break, Dr. Kitchen…
…
continue reading
This month on To the Point, Jackie Garlich, OD, FAAO, introduces her new co-host, Jessilin Quint, OD, MS, MBA, FAAO. Dr. Quint shares her background and journey in optometry, including how she came to open her dry eye and aesthetics clinic 2 years ago in Maine.By Modern Optometry
…
continue reading